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SUMMARY
Incorporation of disulfide bonds into proteins can be
critical for function or stability. In bacterial cells, the
periplasmic enzyme DsbA is responsible for disulfide
incorporation into many extra-cytoplasmic proteins.
The type VI secretion system (T6SS) is a widely
occurring nanomachine that delivers toxic effector
proteins directly into rival bacterial cells, playing a
key role in inter-bacterial competition. We report
that two redundant DsbA proteins are required for
virulence and for proper deployment of the T6SS in
the opportunistic pathogen Serratia marcescens,
with several T6SS components being subject to the
action of DsbA in secreting cells. Importantly, we
demonstrate that DsbA also plays a critical role in
recipient target cells, being required for the toxicity
of certain incoming effector proteins. Thus we reveal
that target cell functions can be hijacked by T6SS
effectors for effector activation, adding a further
level of complexity to the T6SS-mediated inter-
bacterial interactions which define varied microbial
communities.
INTRODUCTION
Formation of specific disulfide bonds between Cys residues is
critical for the function or stability of numerous extra-cyto-
plasmic and secreted proteins. In Gram-negative bacteria,
incorporation of disulfide bonds takes place in the periplasmic
compartment and is orchestrated by the Dsb machinery, which
is well characterized in E. coli and has been reviewed previously
(Hatahet et al., 2014; Kadokura and Beckwith, 2010). The pri-
mary oxidant is DsbA, a periplasmic thiol-disulfide oxidoreduc-
tase that donates a disulfide bond to substrate proteins and is
subsequently re-oxidized by the membrane protein DsbB.
DsbA displays a thioredoxin fold and a CXXC redox-active cata-
lytic motif. When a protein has more than two Cys residues,
DsbA may introduce incorrect disulfide bonds; these are rear-
ranged by the disulfide isomerase DsbC, which is maintained
in a reduced state by DsbD. The presence of DsbA is critical
for virulence in various bacterial pathogens (Shouldice et al.,
2011). It has been shown to be required for folding or stabilization
of secreted virulence factors, such as cholera toxin, and for
biogenesis of adhesion and motility structures. Additionally,
components of certain protein secretion systems also require
DsbA for function or stability (Jameson-Lee et al., 2011; Shoul-
dice et al., 2011). Secretion systems are specialized machineries
used by bacterial cells to deliver proteins to the extracellular
environment or directly into target cells, thus determining bacte-
rial interactions with the host, environment, or competitors
(Costa et al., 2015).
The Type VI secretion system (T6SS) is widespread in Gram-
negative bacteria and used to deliver toxic effector proteins
directly into other cells. T6SSs are macromolecular machineries
formed by 14 conserved core components (TssA-M, PAAR),
often with additional accessory proteins, that assemble to form
amembrane-anchored structure partially resembling an inverted
bacteriophage tail. According to the current model (Basler, 2015;
Brunet et al., 2015; Cianfanelli et al., 2016b; Durand et al., 2015),
a basal complex made up of amembrane complex (TssJLM) and
a cytoplasmic baseplate (TssEFGK) serves as an anchoring plat-
form for the co-ordinated assembly of an extended contractile
sheath (TssBC) around a long spear-like structure (Hcp/TssD,
VgrG/TssI, PAAR) in the cytoplasm. Upon contraction of the
TssBC sheath, the puncturing spear, comprising a tube of
stacked Hcp hexamers tipped with a sharp VgrG-PAAR spike,
is propelled out through the basal complex and can breach a
neighboring target cell. Since varied effector proteins can
associate with components of the expelled spear by covalent
or non-covalent interactions, this ‘‘firing’’ event results in the de-
livery of toxic effector proteins into target cells (Cianfanelli et al.,
2016b; Shneider et al., 2013). The T6SS can act against eukary-
otic cells as a classical virulence factor or, more widely, against
rival bacterial cells as a key weapon in inter-bacterial competi-
tion (Alcoforado Diniz et al., 2015; Russell et al., 2014b). Many
T6SS-delivered antibacterial effectors have now been identified.
These include eight families of cell wall hydrolase (peptidoglycan
amidases and glycoside hydrolases), five families of membrane
phospholipase, several classes of nuclease, predicted pore-
forming toxins, an NAD(P)+ glycohydrolase, and others of un-
known function (Alcoforado Diniz et al., 2015; Russell et al.,
2014a; Whitney et al., 2015). It is noteworthy that the majority
of T6SS antibacterial effectors reported to date, including
peptidoglycan hydrolases and phospholipases, act in the peri-
plasm of target cells, although it is currently unclear in which
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compartment(s) in the target cell effectors are released (Vettiger
and Basler, 2016). In order to avoid self-intoxication, either within
the secreting cell or between neighboring sibling cells, antibac-
terial effectors are neutralized by specific immunity proteins
encoded adjacent to the toxic effector. Immunity proteins are
localized in the compartment of action of the toxin and provide
protection by binding to it with high specificity (Alcoforado Diniz
et al., 2015; Russell et al., 2014a). Although one example of a
target cell protein being required for an effector to access the
cytoplasm has been reported (Whitney et al., 2015), the use of
specific target cell functions for activation of incoming effectors
has not yet been described. DsbA-mediated disulfide bond for-
mation represents a good candidate for such a target cell pro-
cess. However, whether DsbA is required for T6SS function,
either for the secretion machinery itself or for effector activation,
has not yet been determined.
To investigate the role of DsbA in T6SS-mediated antibacterial
activity, we used the T6SS of Serratia marcescens, an opportu-
nistic pathogen frequently isolated as a cause of multidrug resis-
tant human infections or as a virulent insect pathogen (Iguchi
et al., 2014). The T6SS of S. marcescens strain Db10 represents
a good model for studying antibacterial T6SS. Nine antibac-
terial effectors delivered by this system have been described,
including two peptidoglycan hydrolases (Ssp1 and Ssp2), a
DNase (Rhs2), and a predicted phospholipase (Alcoforado Diniz
and Coulthurst, 2015; Cianfanelli et al., 2016a; English et al.,
2012). In this study we aimed to define the role of DsbA during
the effective deployment of the T6SS against competitor bacte-
rial cells. We report that DsbA is required for proper functionality
of the T6SS in the secreting cell, while the presence of a func-
tional DsbA protein in the recipient target cell is necessary for
the toxic action of periplasmic-acting T6SS effectors. This
work reveals a dual role for DsbA in both the donor and recipient
cell during T6SS-mediated inter-bacterial interactions and high-
lights the important finding that target cell functions can be
hijacked for activation of incoming T6SS effectors.
RESULTS
Two Redundant DsbA Homologs Are Required for
Pleiotropic Phenotypes, Including Virulence, in
S. marcescens
Interrogation of the genome sequence of S. marcescens Db10
(Iguchi et al., 2014) revealed the presence of genes encoding
two DsbA homologs, SMDB11_4101 (named DsbA1) and
SMDB11_0239 (DsbA2). Alignment with the well-characterized
single DsbA from E. coli revealed that DsbA1 is more closely
related to E. coli DsbA (71% identity) than DsbA2 (45% identity)
(Figure 1A). To investigate the role and potential redundancy of
the two homologs, in-frame deletion mutants lacking dsbA1,
dsbA2, or both were generated. The DdsbA1 and DdsbA2 mu-
tants showed no growth difference compared with the wild-
type under any condition. The double DdsbA1DdsbA2 mutant
showed no impairment under standard growth conditions (rich
media with good aeration) but did exhibit a minor reduction in
growth rate under conditions of reduced aeration (96-well plate),
particularly in minimal media (Figure S1). Considering pheno-
typespredicted tobeaffectedby lackofDsbA, swimmingmotility
and ampicillin resistance (dependent on endogenous periplas-
mic b-lactamases) were assessed in the DsbA mutants. Neither
motility nor growth in the presence of ampicillin was affected in
the single DdsbA1 and DdsbA2 mutants compared with the
wild-type. In contrast, the DdsbA1DdsbA2 mutant displayed
reduced swimmingmotility in rich media, complete loss of swim-
ming in minimal media, and reduced growth rate in the presence
of ampicillin (Figures 1B and 1C). The loss of motility in the
DdsbA1DdsbA2 mutant could be fully complemented by the
expression of DsbA2 in trans. However, the equivalent overex-
pression of DsbA1 had a deleterious impact on growth and there-
fore could not be used for complementation (Figure S1). We
speculated that the two dsbA homologs might have distinct
roles in virulence. Using theGalleria mellonella (wax moth) larvae
model, the DdsbA1DdsbA2 mutant was found to be essentially
avirulent (LD80 [lethal dose to 80%of larvae] value of107 bacte-
rial cells), compared with the wild-type (LD8010 cells). This loss
of virulence could be fully complemented by the expression of
DsbA2 in trans (Figures 1D and 1E). In contrast, although the
DdsbA1mutant hadaslightly highermeanLD80 value, neither sin-
gle mutant was significantly impaired compared with the wild-
type (p > 0.05, t test). Taken together, these data show that
DsbA1andDsbA2showahighdegreeof redundancy, but at least
one functional DsbA homolog is required for several important
phenotypes, including virulence, in Serratia marcescens.
DsbA Is Required in the Secreting Cell for Full T6SS
Function and Acts on Several Components of the
Secretion Machinery
In order to determine whether DsbA-mediated disulfide
bond formation is required within the T6SS machinery, we
examined T6SS function in wild-type and dsbA mutants of
S. marcescens Db10. First, the basic ability of the system to
‘‘fire’’ Hcp and effector proteins to the media in liquid culture
was determined, revealing that the DdsbA1DdsbA2 mutant
was still able to secrete Hcp and Ssp2, albeit with a reduced ef-
ficiency obvious for Ssp2 (Figure 2A). In contrast, single dsbA
mutants were indistinguishable from the wild-type. The ability
of individual cells within a microcolony to assemble a firing-
competent T6SS can be determined by observing formation of
TssB-mCherry foci (contractile TssBC sheath structures; Gerc
et al., 2015). Here, the DdsbA1DdsbA2 mutant showed a mark-
edly reduced frequency of TssB focus formation compared
with the wild-type (Figure 2B). Finally, we examined the impact
of dsbA deletion on T6SS-mediated antibacterial activity, the
most sensitive measure of proper T6SS function. Although the
single DdsbA1 and DdsbA2 mutants were again indistinguish-
able from the wild-type, the DdsbA1DdsbA2 mutant showed
almost no activity against E. coli and considerably reduced activ-
ity against P. fluorescens (Figures 2C and 2D). Similarly, when
using non-immune mutants of Db10 susceptible to individual
effectors Ssp4 (Figure 2E) or Rhs2 (Figure 2F) as target strains,
the DdsbA1DdsbA2 mutant was greatly impaired. This loss of
antibacterial activity could be fully complemented by expression
of DsbA2 in trans (Figure 2G). However, overexpression of
DsbA1 inhibited the activity of the wild-type strain, consistent
with its negative impact on growth (Figure S1), suggesting that
excess levels of this protein are harmful.
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Given that a functional DsbA homolog is required for proper
T6SS activity, we aimed to determine which component(s) of
the machinery it acts on. Three T6SS proteins were identified
as candidate DsbA substrates, on the basis of the presence
of Cys residues within a protein or domain that is known, or pre-
dicted, to be periplasmically located: TssM (SMDB11_2255),
part of the core membrane complex, and two accessory compo-
nents of unknown function, SMDB11_2251 and SMDB11_2269.
If these proteins are DsbA substrates, their oxidation state
should be altered in the absence of DsbA1 and DsbA2. Label-
ing whole cells with methoxypolyethylene glycol maleimide
(malPEG) allows irreversible labeling of free sulfhydryl groups
in the periplasm (Koch et al., 2012), causing a shift of 5 kDa for
each reduced cysteine labeled. To allow detection, strains en-
coding each candidate protein fused with a C-terminal His6 tag
at the normal chromosomal location were generated and their
T6SS functionality determined. Introduction of the His6 tag in
2251-His and 2269-His had little or no impact on T6SS-depen-
dent antibacterial activity, whereas the TssM-His fusion caused
a small reduction of activity in the wild-type background and
further impaired the already-compromised T6SS function in the
DdsbA1DdsbA2 background (Figure 3A). SMDB11_2251 is a
predicted periplasmic lipoprotein with two Cys residues in addi-
tion to the lipidation site. Upon treatment of the strain encoding
2251-His in DdsbA1DdsbA2 with malPEG, a species with a
10 kDa shift, corresponding to labeling of both reduced Cys res-
idues, could be detected (Figure 3B). No labeled species were
detected in a wild-type background, indicating that both Cys
Figure 1. DsbA1 and DsbA2 Are Redundant and Required for Pleiotropic Phenotypes in S. marcescens
(A) Alignment of the amino acid sequences of DsbA1 (SMDB11_4101) and DsbA2 (SMDB11_0239) from S. marcescens Db10 with the single DsbA homolog from
E. coli K12 (UniProt: P0AEG4). The conserved oxidoreductase catalytic motif (CXXC) is indicated by a red box.
(B) Swimmingmotility of wild-type (WT) or mutant (DdsbA1,DdsbA2, andDdsbA1DdsbA2) strains ofS.marcescensDb10 in rich (LB) orminimalmedia, expressed
as mean diameter of the swim halo ± SEM (n = 4).
(C) Ampicillin resistance of wild-type and mutant strains, as determined by doubling time during growth in minimal media with differing concentrations of
ampicillin. Bars show mean ± SEM (n = 4).
(D) Virulence of wild-type S. marcescensDb10 and mutant strains inGalleria mellonella larvae. Data are expressed as lowest dose of bacteria required to kill 80%
of the larvae (LD80) after 24 hr (with 20 larvae inoculated per group). Individual data points, overlaid with the mean ± SEM, are plotted for n = 7 independent
experiments.
(E) Virulence phenotype of the wild-type and the DdsbA1DdsbA2 mutant carrying the vector control (+VC, pSUPROM) or a plasmid directing the expression of
DsbA2 in trans (+DsbA2, pSC1507) measured as in (D), except that data are from n = 3 independent experiments.
See also Figure S1.
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Figure 2. Loss of DsbA1 and DsbA2 Disrupts the Function of the Type VI Secretion Machinery
(A) Immunoblot detection of Hcp1 and Ssp2 in the cellular and secreted fractions of wild-type (WT) or mutant (DtssE, DdsbA1, DdsbA2, and DdsbA1DdsbA2)
strains of S. marcescens Db10. The DtssE mutant represents a T6SS-inactive control.
(B) Representative fluorescent microscopy images of the DdsbA1DdsbA2mutant and the parental strain (WT) each expressing the TssB-mCherry reporter fusion
together with uniform cytoplasmic GFP. From left to right: DIC image, mCherry channel (TssB-mCherry), and a false-colored merge of TssB-mCherry (red) with
GFP (green).
(legend continued on next page)
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residues had been oxidized during DsbA-dependent disulfide
bond formation. TssM is an integral membrane protein with a
large C-terminal periplasmic domain that contains two Cys res-
idues in S.marcescens. Labeling of TssM-His with malPEG was
unsuccessful because the protein could not be readily detected
in the DdsbA1DdsbA2 mutant. Analysis of total membrane frac-
tions confirmed that levels of TssMwere greatly reduced, almost
undetectable, in the DdsbA1DdsbA2 mutant compared with the
wild-type and could be restored by expression of DsbA2 in trans
(Figure 3C). In contrast, levels of TssJ, a periplasmic lipoprotein
that is also part of the membrane complex but does not contain
any non-lipidated Cys residues, were unaltered. Loss of stability
in the absence of DsbA provides indirect evidence that TssM is
subject to DsbA-dependent disulfide bond formation (Pugsley
et al., 2001). The atomic structure of the C-terminal part of the
periplasmic domain of TssM from enteroaggregative E. coli
has been reported (Durand et al., 2015). Modeling the equivalent
region of S. marcescens TssM suggested that the two Cys resi-
dues are located close in the 3D structure, and disulfide forma-
tion could occur between them (Figure S2). Similar to TssM,
stability of SMDB11_2269, a predicted periplasmic protein with
four Cys residues, was greatly reduced in the DdsbA1DdsbA2
(C–F) Recovery of target organisms E. coliMC4100 (C), P. fluorescens (D), Db10 Dssp4Dsip4 (E), or Db10 Drhs2DrhsI2 (F), following co-culture with wild-type or
mutant strains of S. marcescensDb10 as attackers. TheDssp4Dsip4 andDrhs2DrhsI2 target strains are non-immunemutants ofS. marcescensDb10 sensitive to
Ssp4 and Rhs2, respectively.
(G) Recovery of P. fluorescens following co-culture with wild-type or mutant strains of S. marcescensDb10 carrying either the vector control (+VC, pSUPROM) or
plasmids directing the expression of DsbA1 (+DsbA1, pSC1506) or DsbA2 (+DsbA2, pSC1507) in trans.
For (C)–(G), individual data points overlaid with mean ± SEM (n = 4) are shown, except (F) where n = 5.
Figure 3. Several T6SS Components Are Subject to the Action of DsbA in S. marcescens Db10
(A) Recovery of P. fluorescens following co-culture with wild-type S. marcescens Db10 (WT), the DtssE and DdsbA1DdsbA2 mutants, and strains carrying
chromosomally encoded C-terminal His6 fusions with SMDB11_2251 (2251-His), TssM (TssM-His), or SMDB11_2269 (2269-His) in the parental or
DdsbA1DdsbA2 mutant background. Individual data points are overlaid with mean ± SEM (n = 4).
(B) Mal-PEG labeling of free (reduced) cysteine residues in 2251-His in the parental (WT) or DdsbA1DdsbA2 mutant background. The 2251-His protein was
detected by anti-His6 immunoblot; two exposures of 2251-His in DdsbA1DdsbA2, with and without labeling, are shown to aid clarity. Non-tag indicates control
strains without the 2251-His fusion.
(C) Immunoblot detection of TssM-His in membrane fractions from strains carrying the TssM-His fusion, in the parental orDdsbA1DdsbA2 background, and from
these strains carrying either the vector control (+VC, pSUPROM) or a plasmid directing the expression of DsbA2 (+DsbA2, pSC1507) in trans. Bottom: immunoblot
detection of the Cys-free control protein TssJ and the wild-type strain (WT) is a control with no fusion protein.
(D) As in (C), except that 2269-His and TssJ were detected in whole-cell samples of the strains indicated.
See also Figure S2.
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mutant, implying that this protein is also a DsbA substrate (Fig-
ure 3D). Therefore the action of DsbA1 or DsbA2 affects three
T6SS components, making an important contribution to the
proper function of the system.
The Presence of DsbA in Target Cells Is Essential for the
Activation of Incoming Periplasmic-Acting Effectors
Ssp2 and Ssp4
Because the expelled Hcp-VgrG-PAAR spear, carrying effector
proteins, is assembled in the bacterial cytoplasm and propelled
directly into the target cell through the T6SS basal complex (Bas-
ler, 2015; Durand et al., 2015), effectors should not be exposed in
the periplasm of the secreting cell for disulfide bond incorpora-
tion by DsbA. On the other hand, we considered whether peri-
plasmic-acting effector proteins might require DsbA-dependent
activation in the target cell by the target’s own DsbA proteins.
The Ssp2 and Ssp4 toxins are periplasmic-acting effectors deliv-
ered by the T6SS of S. marcescens Db10 (English et al., 2012;
Fritsch et al., 2013) that each contain three Cys residues. They
therefore represent good candidates for activation by target
cell DsbA. Ssp2 is a Tae4-family amidase toxin that hydrolyses
peptidoglycan (Srikannathasan et al., 2013), but the mode of
toxicity of Ssp4 is unknown. In order to test whether Ssp4 re-
quires DsbA in the target cell for activity, the susceptibility to
Ssp4 of target strains lacking the immunity protein Sip4 in either
a wild-type or a DdsbA1DdsbA2mutant background was deter-
mined. The Dssp4Dsip4mutant was readily inhibited by delivery
of Ssp4, since recovery of the Dssp4Dsip4 target was
greatly reduced in the presence of a wild-type compared with
a Dssp4 attacker. In contrast, the same target lacking DsbA1
and DsbA2 was entirely resistant to Ssp4, with no difference in
recovery between wild-type and Dssp4 attackers (Figure 4A).
Similarly, a target strain lacking the immunity protein Rap2a
is sensitive to the action of Ssp2 when it possesses DsbA but
becomes resistant in a DdsbA1DdsbA2 background (Figure 4B).
In contrast, sensitivity to the cytoplasmic-acting toxin Rhs2
was unaffected in a DdsbA1DdsbA2 target (Figure 4C). The
DdsbA1DdsbA2 mutant itself does not show any sensitivity to
the T6SS of the wild-type, surviving equally well when co-
cultured with a wild-type or a DtssE attacker (Figure S3). To
confirm a requirement for DsbA in the toxicity of the effector pro-
teins, rather than only for their entry or release into the target cell,
Ssp2 and Ssp4 were artificially expressed and targeted to the
periplasm in wild-type or DdsbA mutant E. coli BW25113. In
each case, loss of DsbA (or co-expression of the immunity pro-
tein) provided relief of toxicity (Figures 4D and 4E). Altogether,
these results suggested that a DdsbA mutant of E. coli would
be less susceptible to the T6SS of S. marcescens than the
wild-type. Co-culture assays exposing wild-type or DdsbA
mutant E. coli to S. marcescens confirmed that this was indeed
the case (Figure 4F).
The requirement to have a functional DsbA protein in a target
cell in order to observe effector toxicity strongly suggests that
the effectors contain disulfide bonds in their final, active confor-
mation. Ssp2 contains three Cys residues, one of which, C50,
has been shown to be a catalytic residue during peptidoglycan
cleavage (Srikannathasan et al., 2013). The other two Cys resi-
dues (C140 and C144) are highly conserved in other Tae4-family
amidase effectors, including Ssp1 and Ent. cloacae Tae4, in
which two proteins these Cys residues form disulfide bonds in
the atomic structures (Srikannathasan et al., 2013; Zhang
et al., 2013). Ssp2 is particularly closely related to Ent. cloacae
and Sal. Typhimurium Tae4 homologs (Figure 5A; Srikannatha-
san et al., 2013). Modeling Ssp2 based on the structures of these
two proteins yields a high-confidence model that displays a
structurally conserved disulfide bond between C140 and C144
(Figure 5B). To validate the model, a C144A point mutation
was introduced into Ssp2, abolishing any disulfide formation.
The C144A mutant was as stable as native Ssp2, and both var-
iants were equally stable between wild-type and DdsbA mutant
cells, consistent with effectors needing to be stable without di-
sulfide bonds prior to secretion. However, the C144A mutant
was non-toxic, as shown by its complete inability to complement
a Dssp2 mutant for T6SS-mediated antibacterial activity, con-
firming the requirement for disulfide bond formation in this
effector (Figures 5C and 5D). Ssp4 is much less well character-
ized than Ssp2. Nevertheless, similar to Ssp2, all three of its
Cys residues are required for T6SS-mediated antibacterial activ-
ity (Figure 5E). This is consistent with the active toxin containing
an essential disulfide bond between two of the Cys residues,
while the third may have a catalytic function.
DISCUSSION
This work has revealed a broad and important role for DsbA-
dependent disulfide bond formation in S. marcescens, being
required for phenotypes including motility, virulence, and
T6SS-mediated antibacterial activity. S. marcescens encodes
two DsbA homologs that appear to be entirely redundant, at
least for the phenotypes examined. Multiple homologs of DsbA
have been reported in other species, in which typically they
play different roles in distinct phenotypes (Heras et al., 2010;
Jameson-Lee et al., 2011; Sinha et al., 2004). Therefore
it remains to be determined whether DsbA1 or DsbA2 of
S. marcescens have specific functions under particular condi-
tions or during assembly of other cellular structures or whether
they simply represent a fail-safe, ‘‘belt-and-braces’’ approach
to ensuring correct extra-cytoplasmic protein folding.
DsbA has been reported previously to have a critical role in the
proper functioning of components from three classes of protein
secretion system, Type II, Type III, and Type IV, including the
Type II pseudopilin PulK, the Type III outer membrane secretins
YscC and SpiA, and several core components of the Legionella
Dot/Icm Type IV system (Jackson and Plano, 1999; Jameson-
Lee et al., 2011; Kpadeh et al., 2015; Miki et al., 2004; Pugsley
et al., 2001). Therefore it was of great interest to discover
whether DsbA is also required for the proper function of
the T6SS, the other widespread class of large trans-envelope
secretion machinery. We show that while DsbA is not essential
for the T6SS to fire, absence of both DsbA homologs causes a
marked reduction in the number of assembled T6SSs and results
in a large reduction in T6SS-dependent antibacterial activity.
It should be noted, however, that this loss in T6SS activity is
unlikely to represent a significant contribution to the virulence
defect of the DsbAmutant, since a T6SSmutant shows no defect
in the Galleria model (Murdoch et al., 2011).
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Given that the T6SS is indeed dependent on DsbA for proper
function, we then examined which component(s) are subject to
its action in S. marcescens. Both the core membrane protein
TssM and the predicted accessory protein SMDB11_2269
were found to be highly dependent on the presence of functional
DsbA for their stability, which, together with the presence of pairs
of Cys residues predicted to be available for DsbA-mediated di-
sulfide bonding in the periplasm, implies they are highly likely to
be direct substrates of DsbA. Another predicted accessory pro-
tein also encoded within the S. marcescens T6SS gene cluster,
SMDB11_2251, exhibited DsbA-dependent oxidation, indicating
the presence of a DsbA-dependent intramolecular disulfide
bond. TssM is an integral inner membrane protein that forms
an essential part of the T6SS core membrane complex. The
membrane complex recruits the cytoplasmic baseplate, allowing
subsequent sheath and spear assembly (Brunet et al., 2015; Du-
rand et al., 2015). Therefore loss of TssM stability should explain
some or all of the loss of T6SS function in a DsbAmutant. The re-
sidual activity observed suggests either that a small amount of
TssM can fold without disulfides or that non-specific oxidation
allows a limited amount of spontaneous disulfide formation be-
tween the two periplasmic Cys residues. SMDB11_2269 and
SMDB11_2251 are also subject to DsbA action, however, their
role in the T6SS, and thus the contribution of DsbA through these
proteins, remains to be defined. In agreement with our findings,
two studies in Francisella tularensis identified PdpB, the equiva-
lent of TssM in the highly divergent Francisella T6SS, as a poten-
tial substrate of the DsbA-like oxidoreductase FipB by using a
Figure 4. The Presence of DsbA in Target Cells Is Essential for Intoxication by the Periplasmic-Acting Effectors Ssp2 and Ssp4
(A) Recovery of target strains S. marcescens Db10 Dssp4Dsip4 and Dssp4Dsip4DdsbA1DdsbA2, following co-culture with wild-type Db10 (WT), the Dssp4
effector mutant, or sterile media alone (none) as attacker. Individual data points are overlaid with the mean ± SEM (n = 4).
(B and C) As in (A), except that recovery of the Dssp2Drap2A mutant (B) or the Drhs2DrhsI2 mutant (C), with or without additional DdsbA1DdsbA2 deletions,
following co-culture with the wild-type and the cognate effector mutant was determined.
(D) Growth of wild-type (WT) and DdsbA mutant E. coli BW25113 carrying the vector control (+VC, pBAD18-Kn) or plasmids directing the expression of Ssp4
fused with an N-terminal OmpA signal peptide (+SP-Ssp4, pSC1234) or SP-Ssp4 with Sip4 (+SP-Ssp4,Sip4, pSC861).
(E) Growth of wild-type and DdsbA mutant E. coli BW25113 when carrying plasmids directing the expression of Ssp2 fused with an OmpA signal peptide
(+SP-Ssp2, pSC138) or SP-Ssp2 with Rap2a (+SPSsp2,Rap2a, pSC144). For (D) and (E), strains were grown in LB with 0.002% arabinose. Points show mean ±
SEM (n = 4).
(F) Recovery of control (DlacA::KnR) or DdsbA (DdsbA:: KnR) E. coli BW25113 following co-culture with wild-type or T6SS-inactive (DtssE) S. marcescens Db10.
See also Figure S3.
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substrate-trapping approach (Qin et al., 2016; Ren et al., 2014).
However, the impact of FipB/DsbA on the function of the T6SS
in F. tularensis was not examined. The identification of PdpB
suggests that TssM can be a conserved target of DsbA. How-
ever, TssM is not a universal target, because other homologs,
including the well-characterized TssM of EAEC, do not share a
pair of periplasmic Cys residues, suggesting that a disulfide
bond in TssM may be a system-specific adaptation. Modeling
the C-terminal region of TssM from S. marcescens based on
TssM from EAEC (Durand et al., 2015) showed that formation
of a disulfide bond appears to be plausible and would be away
from the site of interaction with TssJ (Figure S2). Because Cys
1210 is the penultimate residue of S. marcescens TssM, the
disulfide bond may serve to stabilize the C terminus of the pro-
tein. In contrast, EAEC TssM extends another 28 amino acids
beyond the corresponding position, suggesting that the C termi-
nus is configured differently.
Although our data show that DsbA-mediated disulfide bond
formation is required for the full activity of the T6SS machinery
itself, it is unlikely that DsbA acts on any effectors within the
secreting cell. Effectors interact covalently or non-covalently
with the T6SS puncturing spear, either within the lumen of the
Hcp tube or on the exterior of the VgrG/PAAR spike (Cianfanelli
et al., 2016b). This structure is assembled within the cyto-
plasm and is then fired through the periplasm by an extremely
rapid, <2 ms, contraction event (Vettiger et al., 2017). This im-
plies that effectors that ultimately require disulfide bond forma-
tion for activity must be stable in the cytoplasm without disul-
fides, as is observed for Ssp2, even if this is not their final
conformation. In contrast, we have revealed here that incorpora-
tion of disulfide bonds into incoming effectors by the DsbA pro-
tein of the recipient cell can be critical for their toxicity.
There are several possible ways in which target cell functions
might be required for effector toxicity. First, target cell proteins
may be ‘‘hijacked’’ to allow the effector to reach its compartment
of action, similar to how colicins use native outer membrane re-
ceptors and periplasmic translocation machinery to be imported
into susceptible cells, for example use of BtuB, OmpF, and the
Figure 5. Disulfide Bond Formation in Ssp2 Is Required for Toxicity but Not Stability
(A) Sequence alignment of Ssp2 from S. marcescens Db10 (SMDB11_2264), Tae4 from Ent. cloacae (Tae4_Ecl; UniProt: A0A0H3CIJ2), and Tae4 from Sal.
Typhimurium (Tae4_Sty; UniProt: Q93IS4). The catalytic Cys residue is shown in red, and the pair of Cys residues indicated to form a disulfide bond are shown in
yellow.
(B) Structural alignment of Tae4_Ecl (gray) with a model of Ssp2 (green). The Ssp2 model was generated based on the structures of Tae4_Ecl (PDB: 4HFL) and
Tae4_Sty (PDB: 4J32) using iTASSER (C score 1.25, TM score 0.89 ± 0.07), with further refinement by molecular dynamics simulation. Residues involved in the
disulfide bond (Ssp2 Cys140-Cys144) or catalytic triad (Ssp2 Cys50, His131, Asp142) are shown as sticks.
(C) Immunoblot detection of wild-type Ssp2 and Ssp2 C144A in the total cellular fraction of Dssp2 or DdsbA1DdsbA2 strains of S. marcescens Db10. Expression
of Ssp2 and Ssp2 C144A was from pSUPROM-based plasmids pSC1588 (+Ssp2) and pSC1589 (+Ssp2 C144A), respectively.
(D) Recovery of target strain Dssp2Drap2a following co-culture with wild-type (WT) or Dssp2 mutant S. marcescens Db10 carrying the vector control (+VC) or
plasmids directing the expression of Ssp2 and Ssp2 C144A. Individual data points are overlaid with the mean ± SEM (n = 4).
(E) Recovery of target strain Dssp4Dsip4 following co-culture with wild-type or Dssp4 mutant Db10 carrying the vector control (+VC, pBAD18-Kn) or plasmids
directing the expression of Ssp4 (+Ssp4, pSC836), Ssp4 C47A (+Ssp4 C47A, pSC1598), Ssp4 C123A (+Ssp4 C123A, pSC1599), or Ssp4 C165A (+Ssp4 C165A,
pSC2500). Ssp4 variant expression was induced with 0.002% arabinose. Individual data points are overlaid with the mean ± SEM (n = 5).
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Tol-Pal system by ColE2-E9 (Housden and Kleanthous, 2012), or
how contact-dependent inhibition systems engage outer mem-
brane receptors such as BamA and then distinct inner mem-
brane proteins to allow nuclease toxin domains to access the
cytoplasm (Willett et al., 2015). In the case of the T6SS, the ma-
chinery itself allows the target cell to be breached, but it is
currently unclear whether effectors are delivered to the peri-
plasm, cytoplasm, or both, by the firing event. Recent evidence
indicates that Hcp and VgrG proteins can be delivered to the
cytoplasm of the target cell (Vettiger and Basler, 2016), and it
has been proposed that certain periplasmic effectors may be
able to somehow traffic from the cytoplasm to the periplasm
autonomous of the T6SS (Ho et al., 2017). However, there are
many reported examples of periplasmic-acting effectors that
are not toxic when expressed in the cytoplasm (Flaugnatti
et al., 2016; Russell et al., 2012), implying that these effectors
cannot independently traffic to the periplasm and must be deliv-
ered there by the T6SS. Additionally, the first example of a recip-
ient housekeeping protein being required for a T6SS effector to
access its target in the cytoplasm has been reported, namely,
the use of EFTu by the NAD(P)+ glycohydrolase Tse6 (Whitney
et al., 2015). Perhaps most likely is that the T6SS can deliver sto-
chastically to both compartments, but effectors are predomi-
nantly released in the periplasm, from which the minority of
toxins which act in the cytoplasm use target cell proteins to cross
the inner membrane. It is also possible that target cell functions
are required for release of effectors from the T6SSmachinery, for
example, for dissociation from the interior of the Hcp hexamer.
Our finding that periplasmic effectors are frequently subject to
the action of DsbA is consistent with the hypothesis that disulfide
bond formation in the target cell periplasm could be one such
means of effector dissociation, leading to a conformational
change that can release the effector from Hcp, as proposed pre-
viously (Silverman et al., 2013). However, given that DsbA is still
required for activity of Ssp2 and Ssp4when artificially directed to
the periplasm in E. coli, release from Hcp cannot be its only role.
The data presented here reveal that an endogenous target cell
protein can play an essential role in T6SS effector activation.
Incorporation of disulfide bonds by resident DsbA is required
for toxicity of periplasmic effectors, exemplified by Ssp2 and
Ssp4, upon their delivery into a susceptible target cell by the
T6SS. A schematic model for the role of DsbA in target cell
effector activation is presented in Figure 6. Considering the
mechanism of effector activation, conformational change
induced by disulfide bonding may affect catalytic efficiency,
substrate binding, and/or stability in the periplasmic environ-
ment. In the case of Ssp2, the disulfide bond in the closely
related Tae4 protein from Ent. cloacae is also required for toxicity
and plays a role in orienting the catalytic Asp 139 residue and
stabilizing the substrate binding site (Zhang et al., 2013), an
arrangement apparently conserved in Ssp2 (Figure 5B). Simi-
larly, the structure of Ssp1, a distinct member of the Tae4 family,
suggests that a disulfide bond is important to form one side of its
slightly different active site (Srikannathasan et al., 2013). The
molecular details of DsbA contribution to Ssp4 activity are yet
to be determined, however the contribution of DsbA to the
Figure 6. Model for DsbA-Dependent T6SS Effector Activation in Target Cells
When immature effectors are delivered by the T6SS into the periplasm of target cells containing DsbA (top), the recipient cell’s DsbA machinery catalyzes the
introduction of disulfide bonds into incoming effectors, allowing them to adopt their final, active conformation. If the target is a non-self-competitor (top left), the
active effector causes intoxication, for example, cell wall cleavage. If the target is a sibling cell (top right), the corresponding immunity protein intercepts
the effector, preventing toxicity. Alternatively, when effectors that normally require disulfide bond formation are delivered into a competitor target cell lacking
DsbA (bottom left), they remain in the inactive form and do not cause toxicity. In sibling cells, cognate periplasmic immunity proteins may also require disulfide
bond formation, for example, to achieve stability. However, loss of immunity protein function in a sibling cell lacking dsbA does not lead to intoxication, because
the incoming effector is also inactive (bottom right).
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activity of incoming T6SS effectors is likely to be widespread.
Periplasmic immunity proteins may also contain disulfide bonds;
for example, Rap1a andRap2a, which neutralize Ssp1 and Ssp2,
respectively, contain structural disulfide bonds (Srikannathasan
et al., 2013). This might suggest that a DsbA mutant could be
susceptible to its own effectors. However, we observed no killing
of a dsbA mutant by the wild-type, readily explainable by the
cognate effectors being simultaneously non-functional. Consid-
ering inter-species interactions, we observed that loss of DsbA in
E. coli did confer partial resistance to the T6SS ofS.marcescens.
However, given that resistance is incomplete, presumably
because of the delivery of Rhs2 and other DsbA-independent ef-
fectors, this advantage is likely to be outweighed by the fitness
consequences of DsbA loss on other cellular phenotypes.
In conclusion, our findings reveal the dual importance of DsbA
in T6SS-mediated antibacterial activity, both for proper func-
tioning of the machinery in the secreting cell and also for effector
activation in the target cell. The discovery that recipient cell DsbA
is hijacked to activate toxicity of certain effectors represents
an exciting new aspect to understanding T6SS-mediated inter-
bacterial interactions. It highlights that target cell functions, in
addition to the armory of the attacking cell, can determine the
effectiveness of a T6SS-mediated assault, with the cumulative
outcome of such interactions defining the shape of varied poly-
microbial communities.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Plasmids
Bacterial strains and plasmids used in this study are described in Table S1.
Mutant strains of S. marcescens Db10 carrying in-frame deletions or encoding
His-tagged fusions proteins at the normal chromosomal location were con-
structed by allelic exchange using the suicide vector pKNG101 (Murdoch
et al., 2011). Streptomycin (Sm)-resistant derivatives of mutant strains were
obtained by transduction of the resistance allele from S. marcescens Db11
(English et al., 2012). The dsbA and lacA deletion mutants of E. coli
BW25113 were obtained from the Keio collection, and the inserted kanamycin
(Kn)-resistance cassettes were flipped out when required, as described (Dat-
senko and Wanner, 2000). Plasmids for constitutive expression of genes in
trans were derived from pSUPROM and for arabinose-inducible expression
of toxins from pBAD18-Kn, with primer sequences and details of plasmid
construction provided in Table S2. Strains of S. marcescens were grown at
30C, in Luria broth (LB) or in minimal media (40 mM K2HPO4, 15 mM
KH2PO4, 0.1% [NH4]2SO4, 0.4 mM MgSO4, 0.2% [w/v] glucose); media were
solidified with 12 g/L agar. Strains of E. coli were grown at 37C in LB. When
required, media were supplemented with antibiotics: ampicillin 100 mg/mL,
Kn 100 mg/mL, and Sm 100 mg/mL.
Immunodetection of Cellular and Secreted Proteins
Detection of Hcp1 and Ssp2 in cellular and secreted fractions of cultures
grown for 7 hr in LBwas performed as described (English et al., 2012; Murdoch
et al., 2011). For detection of TssM-His, crude membrane fractions were pre-
pared from cultures grown in 25 mL LB for 7 hr. Cells were harvested and
washed in 10 mL of 50 mM Tris-HCl (pH 8), resuspended in 1 mL of 50 mM
Tris-HCl (pH 8), and broken by sonication on ice. Cellular debris was removed
by centrifugation (14,000 3 g, 20 min, 4C), then total membranes were iso-
lated by ultracentrifugation (80,000 3 g, 30 min, 4C) and resuspended in
SDS sample buffer (100 mM Tris-HCl [pH 6.8], 3.2% SDS, 3.2 mM EDTA,
16% glycerol, 0.2 mg/mL bromophenol blue, 2.5% b-mercaptoethanol). To
detect 2269-His in whole-cell samples, cultures were grown as above, and
cells were resuspended in SDS sample buffer and boiled. His6 immunodetec-
tion used an anti-His5 primary antibody (1:6,000; QIAGEN) and a horseradish
peroxidase (HRP)-conjugated anti-mouse secondary antibody (1:10,000;
Bio-Rad). Anti-TssJ polyclonal antibody was used as described (Rao et al.,
2011).
Co-culture Assays for T6SS-Mediated Antibacterial Activity
As described previously (Murdoch et al., 2011), the ‘‘attacker’’ strains of
S. marcescens Db10 and the appropriate ‘‘target’’ strains were each normal-
ized to an optical density at 600 nm (OD600) of 0.5, mixed at a ratio of 1:1,
and co-cultured on solid LB at 30C (or 37C for E. coli) for 7.5 hr (Db10-
derived targets) or 4 hr (all other targets). Target strains were Sm-resistant
derivatives of the strains of interest, except for KnR mutants of E. coli
BW25113 (Table S1). Surviving target cells were enumerated by serial dilution
and viable counts on Sm (or Kn)-supplemented LB agar.
Measurement of Bacterial Growth and Motility
Overnight cultures were diluted 1:200 in fresh media to a final volume of 180 mL
and aliquoted into a 96-well plate. The plate was incubated with continuous
shaking, in a Synergy 2 plate reader (BioTek), and absorbance at 600 nm
(A600) readings were taken every 20 min. To calculate doubling times, the
exponential phase of each individual replicate growth curve was used to fit
an exponential trend line in Microsoft Excel and the doubling time calculated
as ln(2)/c, where c is the growth rate of the population of bacteria, derived
from the equation y = a3 e(c 3 x). Growth rate measurement in flasks was per-
formed on 25 mL cultures inoculated to a starting OD600 of 0.02 and incubated
at 200 rpm. To measure swimming motility, individual bacterial colonies were
used to inoculate LB orminimal media containing 0.3% agar. Plates were incu-
bated at 30C for 16 hr, and the diameter of the swim halo was measured.
Virulence Assay in Galleria mellonella
Virulence was assessed by determining the lethal dose of bacteria necessary
to kill 80% ofGalleria mellonella larvae (Livefoods UK) in 24 hr (LD80). Overnight
bacterial cultures were normalized to an OD600 of 1 and diluted 10
1 to 107 in
PBS. Larvae (n = 20) were injected via the hind left proleg with 10 mL of each
dilution using a Hamilton syringe and incubated at 25C for 24 hr. Larvae
were then scored as live or dead, with ‘‘dead’’ being those that did not respond
to touch. Culture dilutions were simultaneously plated on LB agar plates to
enumerate the number of bacteria in the inocula.
Fluorescence Microscopy
Five milliliter overnight cultures were diluted 1:200 in 25 mLminimal media and
grown for 5 hr with shaking. Two microliters of culture were placed on a micro-
scope slide layered with a pad of minimal media solidified by the addition of
1.5% UltraPure agarose (Invitrogen) and sealed with 1.5 thickness coverslips
attached to the microscope slide with a GeneFrame (Thermo Fisher Scientific).
Images were acquired using a DeltaVision Core wide-field microscope
(Applied Precision) mounted on an Olympus IX71 inverted stand with an
Olympus 100X 1.4 NA lens and a CoolSnap HQ2 camera (Photometrics),
with differential interference contrast (DIC) and fluorescence optics. Images
were acquired with the following parameters: 512 3 512 pixels, one-by-one
binning, with 11 Z sections spaced by 0.25 mm. GFP and mCherry were de-
tected using aGFP filter set (Ex 485/20 nm, Em 530/25 nm) and amCherry filter
set (Ex 542/82, Em 603/78), with exposure time of 100 ms. DIC images were
acquired at 32% intensity and exposure time of 200 ms. Post-acquisition,
images were deconvolved using softWoRx and stored and processed using
OMERO software (Allan et al., 2012).
Sulfhydryl Labeling in Whole Cells
Labeling of free cysteines in intact cells was performed using malPEG as
described (Koch et al., 2012). Cells were grown for 7 hr in 50 mL LB, harvested
by centrifugation (21,000 3 g, 10 min), washed in 10 mL HEPES/MgCl2 buffer
(50 mM HEPES, 5 mM MgCl2 [pH 6.8]), and resuspended in a volume equiva-
lent to 10mL for a culture harvested at OD600 3.0. Labeling reactions were per-
formed for 1 hr at room temperature, in a final volume of 100 mL HEPES/MgCl2
buffer containing 80 mL cell suspension, 5 mM malPEG, and 10 mM EDTA.
Non-labeled control samples had malPEG omitted. Reactions were stopped
by addition of DTT to 100mMfinal concentration. Cells were isolated by centri-
fugation (21,000 3 g, 5 min) and resuspended in 100 mL SDS sample buffer
prior to SDS-PAGE.
Cell Reports 22, 774–785, January 16, 2018 783
In Silico Analysis
Sequence alignments were performed using T-Coffee orMUSCLE (http://www.
ebi.ac.uk/Tools/msa/). Structuremodelswere generatedusing I-TASSER (Yang
et al., 2015). Ssp2model was further regularized by 1 ns molecular dynamics in
explicit solvent followed by energy minimization (Gromacs 2016.3; Abraham
et al., 2015). Structural alignments were performed in PyMol (version 1.8.6.0;
Schrodinger).
Statistical Methods
Quantitative data were analyzed and presented using GraphPad Prism, and
pairwise comparison was performed using unpaired t tests (two tailed). All rep-
licates were independent biological replicates.
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